Eli Lilly's continued advancements in pharmaceutical innovation and their commitment to escalating manufacturing capabilities encapsulate the core of the company's recent endeavors. At the heart of these developments is Eli Lilly’s extensive investment in research and development and the subsequent
Biotechnology startup Constructive Bio has recently garnered attention for its innovative advances in synthetic genomics and engineered protein translation. Winning the Innovation Award at the ELRIG Drug Discovery 2024 event highlights the transformative potential of their technologies. This
Wilson County, located in Eastern North Carolina, has recently become a hotspot for significant economic development, largely driven by substantial investments from pharmaceutical giants. Within the past eight days, the region has received promises of major funding, hinting at a promising future
In a significant development affecting the biotech industry, WuXi AppTec, a leading Chinese manufacturing company, has reported a revenue decline for the first half of 2024. This downward trend coincides with growing concerns about the impending BIOSECURE Act, which aims to restrict U.S.
Arch Venture Partners has announced the closing of their 13th venture fund, known as "Fund XIII," amounting to over $3 billion. This milestone signifies a major revitalization in the biotech investment landscape, targeting the growth and development of early-stage biotechnology companies. By
Uganda’s Leader of Opposition, Joel Ssenyonyi, alongside a group of 15 other Members of Parliament, recently conducted an insightful inspection of the Dei BioPharma facility located in Matugga. This visit, which took place on September 19, 2024, marked a significant milestone that underscored the
Recent advancements in cancer treatments have provided new hope for patients, with significant progress showcased in the biopharmaceutical industry. The interim results of ArriVent BioPharma, Inc.'s Phase 1b FURTHER trial for their drug firmonertinib have been particularly promising. This trial
The ongoing evolution and novel advancements in filtration technology are essential for biologics manufacturing, as the complexity and size of therapeutic modalities increase. This evolution has introduced new challenges that require efficient and effective filtration systems to ensure the
The landscape of biopharmaceutical research and development (R&D) has seen a remarkable evolution, particularly in the realm of oncology. In recent years, a significant portion of R&D investments has been channeled into cancer research, paving the way for groundbreaking treatments and therapies.
In a significant move reflecting the growing regulatory pressure on data security practices, Enzo Biochem has reached a settlement with the Attorneys General of Connecticut, New York, and New Jersey over allegations of inadequate security measures leading to a data breach earlier this year. The
